Importance of antineutrophil cytoplasmic
antibodies in primary sclerosing cholangitis and ulcerative colitis:
prevalence, titre, and IgG subclass
DS Bansi, KA Fleming and RW Chapman
Department of Gastroenterology, University of Oxford, Oxford Radcliffe
Hospital, Headington, UK.
Antineutrophil cytoplasmic antibodies (ANCA) have
been reported in up to 87% of patients with primary sclerosing cholangitis
with or without ulcerative colitis (PSC +/- UC) and in 68% of those
with UC only. Compared with other liver and diarrhoeal diseases,
ANCA have high specificity for PSC (+/- UC) and UC only. This study
aimed to determine the prevalence and significance of ANCA in these
two diseases and whether the ANCA titre or IgG subclass, or both,
could distinguish between PSC + UC and UC only. Subjects included
63 patients with PSC, 85 with UC, 17 with coeliac disease, and 10
with dermatitis herpeteformis and 36 normal subjects. ANCA was detected
using the immunoalkaline phosphatase method. The IgG subclass of
ANCA was determined in 27 PSC + UC and 30 UC only patients using
a panel of mouse monoclonal antibodies specific for the IgG subclasses.
At a serum dilution of 1:5, ANCA had a diagnostic sensitivity of
65% for all PSC and 45% for UC only. For PSC + UC the sensitivity
was 70% at 1:5 (p = 0.004 v UC only). At 1:50, the sensitivity values
were 54% and 25% respectively for PSC + UC and UC only (p = 0.0006).
In PSC, ANCA positivity was significantly associated with extensive
involvement of the biliary tree but not with other clinical parameters.
In UC only, the median disease duration was significantly greater
in ANCA positive patients. The PSC + UC ANCA showed increased IgG3
compared with UC only ANCA (p < 0.05), together with increased
IgG2 and IgG4 (p = NS). ANCA is a diagnostic marker in PSC and UC.
While the higher titres and different IgG subclass distribution
of ANCA in PSC + UC patients compared with those with UC only may
reflect differences in underlying immune regulation, determination
of the ANCA titre and IgG subclass is unlikely to have a role in
distinguishing between PSC + UC and UC only ANCA. Future identification
of the antigen(s) for ANCA should allow the development of a more
sensitive and specific test for the diagnosis of these two conditions
and also determine if ANCA is associated with UC or PSC.
|